XGN Stock Analysis: Buy, Sell, or Hold?
XGN - Exagen Inc. Common Stock
$7.67
0.07 (0.92%)
▲
5d:
+3.23%
30d:
+72.36%
90d:
+53.09%
WAIT
LOW Confidence
Analysis Updated: Aug 26, 2026 12:00 AM ET
Earnings: Aug 04, 2026
0d
Get Alerted When XGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: XGN shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: XGN shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: XGN is currently trading at $7.67, which is considered extended relative to its 30-day fair value range of $4.86 to $7.31.
Technical Outlook: Technically, XGN is in a strong uptrend. Immediate support is located at $6.49, while resistance sits at $7.99.
Market Sentiment: XGN scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $9.86 (+28.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, XGN is in a strong uptrend. Immediate support is located at $6.49, while resistance sits at $7.99.
Market Sentiment: XGN scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $9.86 (+28.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$4.86 -
$7.31
Company Quality Score
37/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
41.7%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 28.5% below Wall St target ($9.86)
- WARNING: Composite score 37/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$4.86 -
$7.31
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$1.26
(16.5%)
Support & Resistance Levels
Support Level
$6.49
Resistance Level
$7.99
Current Trend
Strong Uptrend
Technical data as of
Aug 26, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-17.43
Wall Street Target
$9.86
(+28.5%)
Revenue Growth (YoY)
15.9%
Profit Margin
-26.6%
Share & Embed Analysis
Last updated: August 26, 2026 7:06 PM ET
Data refreshes hourly during market hours. Next update: 8:06 PM
Data refreshes hourly during market hours. Next update: 8:06 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
John Aballi
SELL
15698 shares
2026-03-03
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$631 | 38 SELL |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$194 | 45 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$228 | 40 SELL |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$337 | 33 SELL |
